Female Sex is an Independent Predictor of Death and Bleeding Among Fibrinolytic Treated Patients With AMI

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 2001

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Myocardial Infarction
Interventions
DRUG

fibrinolytic therapy or combination reduced fibrinolytic therapy

Trial Locations (1)

10016

NYU School of Medicine, New York

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Cleveland Clinic

OTHER

collaborator

Centocor, Inc.

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

lead

NYU Langone Health

OTHER